
DM for medical students
Authored by ดารารัตน์ undefined
Health Sciences
University
Used 3+ times

AI Actions
Add similar questions
Adjust reading levels
Convert to real-world scenario
Translate activity
More...
Content View
Student View
10 questions
Show all answers
1.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
In a patient with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or high ASCVD risk, which drug class should be considered first?
Metformin
Sulfonylureas
GLP-1 RA or SGLT2i
DPP-4 Inhibitors
Answer explanation
In patients with T2DM and high ASCVD risk, GLP-1 receptor agonists (RA) or SGLT2 inhibitors (i) are preferred first-line due to their cardiovascular benefits, regardless of initial HbA1c levels.
2.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Which diabetes medication is most associated with a high risk of hypoglycemia?
Metformin
SGLT2i
Sulfonylureas
DPP-4 Inhibitors
Answer explanation
Sulfonylureas are known to stimulate insulin release from the pancreas, which can lead to a significant risk of hypoglycemia. In contrast, Metformin, SGLT2 inhibitors, and DPP-4 inhibitors have a lower risk of causing low blood sugar.
3.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Which diabetes medication should be avoided in patients with heart failure?
Thiazolidinediones
Metformin
GLP-1 RA
SGLT2i
Answer explanation
Thiazolidinediones should generally be avoided in patients with heart failure with reduced ejection fraction (HFrEF) due to their potential to cause fluid retention, worsening heart failure symptoms.
4.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Which of the following is NOT a common side effect of Metformin?
Nausea
Weight gain
Lactic acidosis
Diarrhea
Answer explanation
Weight gain is not a common side effect of Metformin; in fact, it often leads to weight loss. Nausea, diarrhea, and lactic acidosis are known side effects associated with this medication.
5.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Which of the following is NOT a recognized benefit of SGLT2 Inhibitors?
Cardiovascular disease (CVD) risk reduction
Improvement in insulin sensitivity in peripheral tissues
Reduction in heart failure (HF) hospitalization
Slowing of chronic kidney disease (CKD) progression
Answer explanation
SGLT2 inhibitors primarily benefit cardiovascular health, heart failure, and kidney function. They do not significantly improve insulin sensitivity in peripheral tissues, making this the correct choice.
6.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
According to current guidelines, what is the most common initial insulin type recommended for patients with Type 2 Diabetes when insulin therapy is needed?
Basal insulin
Premixed insulin
Mealtime (bolus) insulin
Intravenous insulin
Answer explanation
Current guidelines widely recommend initiating basal insulin as the first step for most Type 2 Diabetes patients requiring insulin, due to its effectiveness in controlling fasting glucose.
7.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Which of the following statements is NOT generally true about DPP-4 Inhibitors?
They carry a high risk of hypoglycemia as monotherapy.
They primarily work by enhancing incretin hormone effects.
They are oral medications.
They are weight-neutral.
Answer explanation
DPP-4 inhibitors do not carry a high risk of hypoglycemia as monotherapy, making this statement NOT generally true. They enhance incretin effects, are oral medications, and are considered weight-neutral.
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports

Continue with Google

Continue with Email

Continue with Classlink

Continue with Clever
or continue with

Microsoft
%20(1).png)
Apple
Others
Already have an account?